# Forensic Dossier: Study Forensics: Amyloid-targeting antibody improves biomarkers without cognitive benefit

**Run ID:** `mech_study-forensics-029_claude_sonnet_6475cd`  
**Task:** study-forensics-029 | study_forensics | medium | study_forensics  
**Timestamp:** 2026-04-06T15:44:22.452299+00:00  
**Task Family:** mechanism_vs_evidence  
**Trap Type:** biomarker_without_clinical_benefit  
**Ambiguity:** low  

## Executive Summary

**Agents tested:** Claude Sonnet
**Winner:** Claude Sonnet — **35.7/100** (margin: 0.0)
**Failure modes:** decorative_self_check, decorative_uncertainty, unsupported_conclusion, wrong_answer
**Forensic flags:** 2
**Consistency findings:** 9
**Answer convergence:** all agents agree

## Score Matrix

| Agent | Correctness | Support Strength | Structural Reaso | Assumption Disci | Uncertainty Hand | Alternative Hypo | Self Monitoring  | Insight Depth | Mechanism Qualit | Communication Ef | **Total** |
|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|
| Claude Sonnet | 0.0/30 | 0.0/8 | 4.8/8 | 4.8/6 | 3.6/6 | 4.5/6 | 0.0/8 | 8.0/8 | 0.0/10 | 10.0/10 | **35.7/100** |

## Study Forensics Audit

### Claude Sonnet

**Classification:** `solid` [x] (gold: `mechanism_vs_evidence`)
**Finding Recall:** 100%
**Matched Findings:** mechanism_not_demonstrated, conclusion_exceeds_results
**Extra Findings:** cautious_scope_control, none_or_minor, correlation_as_causation

## Reasoning Integrity Audit

### Claude Sonnet
**Classification:** Correct and well-supported
**Load-bearing steps:** 0 / 6

## Mechanism Analysis

### Claude Sonnet
| Aspect | Status |
|--------|--------|
| Concept named | :x: none |
| Mechanism described | :x: (0 sentence(s)) |
| Grounded to case | :x: (0 sentence(s)) |

**Missing:** concept not named, mechanism not described, mechanism not grounded to case data

## Grounding Audit

### Claude Sonnet
Conclusion claims: 1
- Direct support: 0
- Indirect support: 0
- Unsupported: 1
- Contradicted: 0

**Unsupported claims:**
- "solid"


## Forensic Flags

### Claude Sonnet

- **[MAJOR]** `well_reasoned_wrong`: Wrong answer but structured reasoning — may have a subtle logic error
  - `final_answer`: "solid"
- **[MODERATE]** `unsupported_conclusion_claims`: 1/1 conclusion claims lack step support
  - `final_answer`: "solid"


## Evidence Map

### Claude Sonnet

**Correctness:** 0.0/30
  - (+) `final_answer`: "solid"
    _Agent's answer for correctness check_
  - Note: No match (got: solid)

**Support Strength:** 0.0/8
  - (-) `final_answer`: "solid"
    _Conclusion not supported by steps_
  - Note: Support classification: 0 load-bearing, 0 supporting, 0 mentioned / 6
  - Note: Reasoning graph: conclusion not well grounded

**Structural Reasoning:** 4.8/8
  - (+) `steps[2]`: "Observed that investigators clearly acknowledged the failure to show cognitive benefits despite biomarker improvements"
    _Most informative reasoning step_
  - Note: 6 reasoning steps
  - Note: Low step utility: 0/6 steps contribute

**Assumption Discipline:** 4.8/6
  - (+) `assumptions[1]`: "The study measured both biomarkers (amyloid plaques, neurodegeneration markers) and cognitive outcomes"
    _Most substantive assumption_
  - Note: 4/4 substantive assumptions

**Uncertainty Handling:** 3.6/6
  - (+) `uncertainties[2]`: "Don't know the exact statistical power for cognitive endpoints"
    _Most substantive uncertainty_
  - (+) `confidence`: "confidence: 0.9"
    _Stated confidence level_
  - (-) `uncertainties[3]`: "Uncertain about the duration of follow-up"
    _Listed but never addressed in reasoning_
  - Note: 4 uncertainties (4 substantive)
  - Note: 1 decorative uncertainty(ies)

**Alternative Hypothesis Quality:** 4.5/6
  - (+) `alternative_hypotheses[1]`: "Could be 'mechanism_vs_evidence' if they assumed biomarker changes would translate to cognitive benefits"
    _Most substantive alternative hypothesis_
  - Note: 3 alternative hypotheses considered
  - Note: 3/3 genuinely diverse alternatives

**Self Monitoring Quality:** 0.0/8
  - (+) `self_check[3]`: "Ensured I'm not penalizing honest reporting of negative results"
    _Most substantive self-verification step_
  - (-) `self_check[0]`: "Verified I'm not fabricating problems where none exist"
    _Fluff self-check_
  - Note: 4 self-check items
  - Note: Self-check quality: 0 deep, 0 arithmetic, 4 fluff

**Mechanism Quality:** 0.0/10
  - Note: Neither names concept nor explains mechanism

**Communication Efficiency:** 10.0/10
  - Note: Signal density: 0.74, 255 words

**Insight Depth:** 8.0/8
  - Note: Key insights: 2 full / 2


## Failure Analysis

### Claude Sonnet

**CRITICAL:**
- **Wrong Answer** `[HIGH CONFIDENCE]`: Answer does not match expected 'mechanism_vs_evidence'
  - `final_answer`: "solid"
  - _Impacts: correctness_

**MAJOR:**
- **Wrong Answer** `[HIGH CONFIDENCE]`: Study classification incorrect: expected 'mechanism_vs_evidence', detected 'solid'
  - `final_answer`: "solid"
  - _Impacts: correctness_

**MODERATE:**
- **Unsupported Conclusion** `[MEDIUM CONFIDENCE]`: Final answer lacks load-bearing or supporting step grounding
  - `final_answer`: "solid"
  - _Impacts: support_strength_

**MINOR:**
- **Decorative Self Check** `[HEURISTIC]`: All 4 self-checks appear to be fluff — no substantive verification
  - `self_check[0]`: "Verified I'm not fabricating problems where none exist"
  - _Impacts: self_monitoring_quality_

**STYLISTIC:**
- **Decorative Uncertainty** `[HEURISTIC]`: Uncertainty 'Uncertain about the duration of follow-up...' is listed but not addressed
  - `uncertainties[3]`: "Uncertain about the duration of follow-up"
  - _Impacts: uncertainty_handling_


## Consistency & Grounding Audit

### Claude Sonnet

- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 1 has low overlap with final answer (0/8 content words)
  - `key_claims[0]`: "The study appropriately separates biomarker success from clinical efficacy"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 2 has low overlap with final answer (0/6 content words)
  - `key_claims[1]`: "Investigators honestly acknowledge the lack of cognitive benefits"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 3 has low overlap with final answer (0/9 content words)
  - `key_claims[2]`: "No unsupported causal claims are made between biomarker changes and cognitive outcomes"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 4 has low overlap with final answer (0/7 content words)
  - `key_claims[3]`: "The research maintains appropriate scientific humility about unproven benefits"
- **[WARN]** `[HEURISTIC]` `decorative_uncertainty`: Uncertainty 4 appears decorative — not addressed in reasoning or self-check
  - `uncertainties[3]`: "Uncertain about the duration of follow-up"
- **[NOTE]** `[HEURISTIC]` `self_check_depth`: Self-check 3 appears to be generic fluff rather than substantive verification
  - `self_check[2]`: "Double-checked that investigators acknowledge limitations"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 1 is stated without rejection reasoning
  - `alternative_hypotheses[0]`: "Could be 'overclaim' if investigators were overstating biomarker significance"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 2 is stated without rejection reasoning
  - `alternative_hypotheses[1]`: "Could be 'mechanism_vs_evidence' if they assumed biomarker changes would translate to cognitive bene"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 3 is stated without rejection reasoning
  - `alternative_hypotheses[2]`: "Could be 'correlation_vs_causation' if they implied biomarker improvements meant cognitive success"


## Agent Profiles

### Claude Sonnet (claude-sonnet-4-20250514)
**Parse OK:** True | **Latency:** 11135ms

**Final Answer:** solid

**Confidence:** 0.9

**Assumptions:**
- This is a Phase 2/3 randomized trial testing a monoclonal antibody
- The study measured both biomarkers (amyloid plaques, neurodegeneration markers) and cognitive outcomes
- The trial had adequate power to detect cognitive effects if they existed
- The investigators are being honest about the lack of cognitive benefits

**Reasoning Steps:**
1. Identified that this is a well-designed randomized trial with appropriate primary and secondary endpoints
2. Noted that the study measured both biological markers and clinical outcomes
3. Observed that investigators clearly acknowledged the failure to show cognitive benefits despite biomarker improvements
4. Recognized that the researchers are appropriately cautious about claiming clinical efficacy
5. Found no evidence of overclaiming - they explicitly state cognitive benefits remain unproven
6. Confirmed no correlation/causation confusion - they don't claim biomarker changes cause cognitive improvement

**Key Claims:**
- The study appropriately separates biomarker success from clinical efficacy
- Investigators honestly acknowledge the lack of cognitive benefits
- No unsupported causal claims are made between biomarker changes and cognitive outcomes
- The research maintains appropriate scientific humility about unproven benefits

**Alternative Hypotheses:**
- Could be 'overclaim' if investigators were overstating biomarker significance
- Could be 'mechanism_vs_evidence' if they assumed biomarker changes would translate to cognitive benefits
- Could be 'correlation_vs_causation' if they implied biomarker improvements meant cognitive success

**Uncertainties:**
- Cannot assess the full study design details from this summary
- Unclear what specific cognitive measures were used
- Don't know the exact statistical power for cognitive endpoints
- Uncertain about the duration of follow-up

**Self-Verification:**
- Verified I'm not fabricating problems where none exist
- Confirmed the text shows appropriate scientific caution
- Double-checked that investigators acknowledge limitations
- Ensured I'm not penalizing honest reporting of negative results

**Dimension Scores:**
- Correctness: 0.0/30 `..........`
- Support Strength: 0.0/8 `..........`
- Structural Reasoning: 4.8/8 `######....`
- Assumption Discipline: 4.8/6 `########..`
- Uncertainty Handling: 3.6/6 `######....`
- Alternative Hypothesis Quality: 4.5/6 `#######...`
- Self Monitoring Quality: 0.0/8 `..........`
- Insight Depth: 8.0/8 `##########`
- Mechanism Quality: 0.0/10 `..........`
- Communication Efficiency: 10.0/10 `##########`


## Final Verdict

**Solo run: Claude Sonnet** scored **35.7/100**.

**Best per dimension:**
- Correctness: Claude Sonnet (0.0/30)
- Support Strength: Claude Sonnet (0.0/8)
- Structural Reasoning: Claude Sonnet (4.8/8)
- Assumption Discipline: Claude Sonnet (4.8/6)
- Uncertainty Handling: Claude Sonnet (3.6/6)
- Alternative Hypothesis Quality: Claude Sonnet (4.5/6)
- Self Monitoring Quality: Claude Sonnet (0.0/8)
- Insight Depth: Claude Sonnet (8.0/8)
- Mechanism Quality: Claude Sonnet (0.0/10)
- Communication Efficiency: Claude Sonnet (10.0/10)

**Latency vs Quality:**

| Agent | Latency | Score | Points/sec |
|-------|---------|-------|------------|
| Claude Sonnet | 11.1s | 35.7/100 | 3.2 |

Failure modes observed: decorative_self_check, decorative_uncertainty, unsupported_conclusion, wrong_answer.
